Dr Reddys Laboratories Ltd
company logo

Dr Reddys Laboratories Ltd

Pharmaceuticals
Large Cap

-

- (0%)


Dr Reddys Laboratories Ltd Performance

-

-

-

-


-

-

-

-

-

Dr Reddys Laboratories Ltd Fundamentals

1,10,827.47Cr

20.11

3.91

0.06

330.41

0.60%

1,699.57

i buttonClick here to know more about Fundamentals

Dr Reddys Laboratories Ltd F&O

Dr Reddys Laboratories Ltd Option Chainright-arrow

Dr Reddys Laboratories Ltd Financials

Dr Reddys Laboratories Ltd Financialsright-arrow

Dr Reddys Laboratories Ltd Shareholding Pattern

Dr Reddys Laboratories Ltd Delivery and Volume

About Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd Share Price 

Dr. Anji Reddy founded Dr. Reddy's Laboratories in 1984 in Hyderabad, India, with an initial capital of ₹25 lakh. After starting to produce Active Pharmaceutical Ingredients and Intermediates (APIs), the business introduced methyldopa to the gl

-

1984

DRREDDY

NameDesignation
G V PrasadCo-Chairman & Managing Directo
K Satish ReddyExecutive Chairman
Kalpana MorpariaIndependent Director
Satish Reddy Vice Chairman & M.D.
Shikha Sanjaya SharmaIndependent Director
Anupam Puri Director
J P Moreau Director
Leo PuriIndependent Director
K P KrishnanIndependent Director
Omkar Goswami Director
Pennv WanIndependent Director
Ravi Bhoothalingam Director
K Randhir SinghCompany Sec. & Compli. Officer
Arun M. KumarIndependent Director
Sandeep Poddar Company Secretary
Bruce L A Carter Director
Claudio AlbrechtIndependent Director
Ashok Sekhar Ganguly Director
Sanjiv MehtaIndependent Director
Sridar Iyengar Additional Director
Alpna SethIndependent Director
News and Events...

Similar Stocks

What's Trending

Dr Reddys Laboratories Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Dr Reddys Laboratories Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Dr Reddys Laboratories Ltd's share price is ₹6646.05 as of 2024-07-17.
Dr Reddys Laboratories Ltd's P/E ratio is 20.11 times as of 2024-07-17.
Dr Reddys Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 3.91, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Dr Reddys Laboratories Ltd's market capitalization is ₹110827.47 Cr as on 2024-07-17.
The current financial records of Dr Reddys Laboratories Ltd show a 19.42% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Dr Reddys Laboratories Ltd's most recent financial filings, the company has a total asset value of ₹13698, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Dr Reddys Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Dr Reddys Laboratories Ltd's 52-week high and low as of 2024-07-17 are ₹6782.95 and ₹6636.65, respectively.